NMPA Approval

Tirofiban Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20193063

Company天津红日药业股份有限公司

Registration Date

November 3, 2023

Drug Information

Generic Name

盐酸替罗非班氯化钠注射液

Dosage Form

注射剂

Strength

100ml∶5mg（以替罗非班计）与 0.9g 氯化钠

Drug Type

化学药品

Registration Date

November 3, 2023

Company Information

Applicant Company

Company Name天津红日药业股份有限公司

Company Address

天津新技术产业园区武清开发区泉发路西

Manufacturing Company

Company Name天津红日药业股份有限公司

Company Address

天津新技术产业园区武清开发区泉发路西；天津新技术产业园区武清开发区源泉路17号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸替罗非班氯化钠注射液 - NMPA 批准文号 | MedPath